2.50
Hdl Handle:
http://hdl.handle.net/10755/202050
Type:
Presentation
Title:
Medication-Related Falls Around the World: A Meta-Analysis
Abstract:
(41st Biennial Convention) Purpose:  To evaluate the effect of newer psychotropic agents on the risk of hip fracture in older adults, using a meta-analytic approach. Background:  Guidelines  and policy in the U.S. and internationally are based on studies that do not adequately reflect recently marketed drugs including atypical antipsychotic agents, selective serotonin reuptake inhibitor (SSRI) antidepressants, and newer GABA-agonist hypnotic agents. While it was postulated that newer agents do not increase falls, recent meta-analyses show that SSRI do increase fall risk.  There are insufficient studies of the newer hypnotic agents to conduct a meta-analysis. While antipsychotic drugs are reputed to be the highest risk category of psychotropics, there has been no meta-analysis comparing conventional and newer atypical antipsychotic agents.  In addition, falls resulting in injury are the true target of fall prevention. Therefore, this meta-analysis focused on the association of conventional and atypical antipsychotic drugs with hip fracture, a common and debilitating fall-related injury. Methods:  A search of Pubmed/Medline was conducted from 1966-2010 with key words including [antipsychotic agents; psychotropic drugs;  or atypical antipsychotic drugs] and [age factor; aged] and [hip fracture;  fractures, bone/etiology or fractures, bone/chemically induced]. Inclusion criteria included comparison of drug exposed fallers and non-fallers;  mean age  > 65 years, and statistical adjustment or stratification or age and gender. Excluded were studies where hip fractures were not distinguished from other fracture types, adjusted odds ratios were not reported, or failure of authors to answer queries for required information.   Results/Conclusions:  Of 121 studies identified, only four studies totaling 51,470 subjects from multiple nations met inclusion criteria.  Preliminary odds ratio for conventional antipsychotic drugs is 1.66 (95% CI: 1.39, 1.98); for the atypical antipsychotic drugs odds ratio is 1.29 (95% CI: 1.12, 1.48).  Both classes increase risk of hip fracture in older adults.  Implications for updating policy and guidelines are considered.
Keywords:
falls; medications; older adults
Repository Posting Date:
11-Jan-2012
Date of Publication:
4-Jan-2012
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleMedication-Related Falls Around the World: A Meta-Analysisen_GB
dc.identifier.urihttp://hdl.handle.net/10755/202050-
dc.description.abstract(41st Biennial Convention) Purpose:  To evaluate the effect of newer psychotropic agents on the risk of hip fracture in older adults, using a meta-analytic approach. Background:  Guidelines  and policy in the U.S. and internationally are based on studies that do not adequately reflect recently marketed drugs including atypical antipsychotic agents, selective serotonin reuptake inhibitor (SSRI) antidepressants, and newer GABA-agonist hypnotic agents. While it was postulated that newer agents do not increase falls, recent meta-analyses show that SSRI do increase fall risk.  There are insufficient studies of the newer hypnotic agents to conduct a meta-analysis. While antipsychotic drugs are reputed to be the highest risk category of psychotropics, there has been no meta-analysis comparing conventional and newer atypical antipsychotic agents.  In addition, falls resulting in injury are the true target of fall prevention. Therefore, this meta-analysis focused on the association of conventional and atypical antipsychotic drugs with hip fracture, a common and debilitating fall-related injury. Methods:  A search of Pubmed/Medline was conducted from 1966-2010 with key words including [antipsychotic agents; psychotropic drugs;  or atypical antipsychotic drugs] and [age factor; aged] and [hip fracture;  fractures, bone/etiology or fractures, bone/chemically induced]. Inclusion criteria included comparison of drug exposed fallers and non-fallers;  mean age  > 65 years, and statistical adjustment or stratification or age and gender. Excluded were studies where hip fractures were not distinguished from other fracture types, adjusted odds ratios were not reported, or failure of authors to answer queries for required information.   Results/Conclusions:  Of 121 studies identified, only four studies totaling 51,470 subjects from multiple nations met inclusion criteria.  Preliminary odds ratio for conventional antipsychotic drugs is 1.66 (95% CI: 1.39, 1.98); for the atypical antipsychotic drugs odds ratio is 1.29 (95% CI: 1.12, 1.48).  Both classes increase risk of hip fracture in older adults.  Implications for updating policy and guidelines are considered.en_GB
dc.subjectfallsen_GB
dc.subjectmedicationsen_GB
dc.subjectolder adultsen_GB
dc.date.available2012-01-11T11:07:22Z-
dc.date.issued2012-01-04en_GB
dc.date.accessioned2012-01-11T11:07:22Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.